Top Suppliers:I want be here

1000793-42-9

1000793-42-9 structure
1000793-42-9 structure

Name 2-(6-bromo-2,3-dihydro-1,4-benzoxazin-4-yl)-6,6-dimethyl-5,7-dihydro-[1,3]thiazolo[5,4-c]pyridin-4-one
Synonyms Thiazolo[5,4-c]pyridin-4(5H)-one, 2-(6-bromo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)-6,7-dihydro-6,6-dimethyl
2-(6-Bromo-2H-benzo[b][1,4]oxazin-4(3H)-yl)-6,6-dimethyl-6,7-dihydrothiazolo[5,4-c]pyridin-4(5
2-(6-broMo-2H-benzo[b][1,4]oxazin-4(3H)-yl)-6,6-diMethyl-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one
2-(6-Bromo-2H-benzo[b][1,4]oxazin-4(3H)-yl)-6,6-dimethyl-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)
Molecular Formula C16H16BrN3O2S
Molecular Weight 394.28600
Exact Mass 393.01500
PSA 82.70000
LogP 3.89440
HS Code 2934999090

~78%

1000793-42-9 structure

1000793-42-9

Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ; Location in patent: Page/Page column 293 ;

~15%

1000793-42-9 structure

1000793-42-9

Literature: UCB PHARMA S.A. Patent: WO2009/71888 A1, 2009 ; Location in patent: Page/Page column 73-74 ; WO 2009/071888 A1

~80%

1000793-42-9 structure

1000793-42-9

Literature: Petter, Russell C.; Jewell, Charles F.; Lee, Kwangho; Medikonda, Aravind Prasad; Niu, Deqiang; Qiao, Lixin; Singh, Juswinder; Zhu, Zhendong Patent: US2011/269244 A1, 2011 ; Location in patent: Page/Page column ;

~%

1000793-42-9 structure

1000793-42-9

Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ;

~%

1000793-42-9 structure

1000793-42-9

Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ;

~%

1000793-42-9 structure

1000793-42-9

Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ;

~%

1000793-42-9 structure

1000793-42-9

Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ;

~%

1000793-42-9 structure

1000793-42-9

Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ;

~%

1000793-42-9 structure

1000793-42-9

Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ;
HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.